These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6541714)

  • 1. A prospective randomized trial of central venous catheter removal versus intravenous amphotericin B in febrile neutropenic patients.
    Lazarus HM; Lowder JN; Anderson JM; Herzig RH
    JPEN J Parenter Enteral Nutr; 1984; 8(5):501-5. PubMed ID: 6541714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP
    Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract]   [Full Text] [Related]  

  • 3. Three-step empiric treatment for severely neutropenic patients with fever: ceftazidime--vancomycin--amphotericin B.
    Koeppler H; Pflueger KH; Seitz R; Havemann K
    Infection; 1989; 17(3):142-5. PubMed ID: 2661438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
    Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric amphotericin B therapy: the need for a reappraisal.
    Fraser IS; Denning DW
    Blood Rev; 1993 Dec; 7(4):208-14. PubMed ID: 8130683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
    Maertens JA; Madero L; Reilly AF; Lehrnbecher T; Groll AH; Jafri HS; Green M; Nania JJ; Bourque MR; Wise BA; Strohmaier KM; Taylor AF; Kartsonis NA; Chow JW; Arndt CA; DePauw BE; Walsh TJ;
    Pediatr Infect Dis J; 2010 May; 29(5):415-20. PubMed ID: 20431381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
    Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    Tan BH; Low JG; Chlebicka NL; Kurup A; Cheah FK; Lin RT; Goh YT; Wong GC
    Int J Infect Dis; 2011 May; 15(5):e350-6. PubMed ID: 21397541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid infusion amphotericin B: effective and well-tolerated therapy for neutropenic fever.
    Spitzer TR; Creger RJ; Fox RM; Lazarus HM
    Pharmatherapeutica; 1989; 5(5):305-11. PubMed ID: 2748690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
    Sobel JD
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.
    Schiel X; Link H; Maschmeyer G; Glass B; Cornely OA; Buchheidt D; Wilhelm M; Silling G; Helmerking M; Hiddemann W; Ostermann H; Hentrich M
    Infection; 2006 Jun; 34(3):118-26. PubMed ID: 16804654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B.
    Lopez-Berestein G; Hopfer RL; Mehta R; Mehta K; Hersh EM; Juliano RL
    Antimicrob Agents Chemother; 1984 Mar; 25(3):366-7. PubMed ID: 6721469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empiric therapy with amphotericin B in febrile granulocytopenic patients.
    Walsh TJ; Lee J; Lecciones J; Rubin M; Butler K; Francis P; Weinberger M; Roilides E; Marshall D; Gress J
    Rev Infect Dis; 1991; 13(3):496-503. PubMed ID: 1866556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.
    Cagnoni PJ; Walsh TJ; Prendergast MM; Bodensteiner D; Hiemenz S; Greenberg RN; Arndt CA; Schuster M; Seibel N; Yeldandi V; Tong KB
    J Clin Oncol; 2000 Jun; 18(12):2476-83. PubMed ID: 10856108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy.
    Stam WB; Aversa F; Kumar RN; Jansen JP
    Value Health; 2008; 11(5):830-41. PubMed ID: 18494752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case report: a Fusarium fungaemia].
    Yücesoy M; Ergon MC; Oren H; Gülay Z
    Mikrobiyol Bul; 2004 Jul; 38(3):265-71. PubMed ID: 15490848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters.
    Averbuch D; Makhoul R; Rotshild V; Weintraub M; Engelhard D
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):527-32. PubMed ID: 18797200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.